Public Policy

New Mexico Governor Signs Major Healthcare Reform Laws
Public Policy New Mexico Governor Signs Major Healthcare Reform Laws

The architectural skeleton of the new Valencia County Hospital in Los Lunas served as more than just a backdrop this week; it stood as a tangible symbol of a state finally aggressive enough to overhaul its own survival mechanisms. Governor Michelle Lujan Grisham has officially signed a suite of

Can States Protect Your Right to No-Cost Birth Control?
Public Policy Can States Protect Your Right to No-Cost Birth Control?

The legal architecture of American reproductive healthcare is currently facing a transformative period as the promise of universal, no-cost contraception encounters significant regulatory and judicial pushback. Since the implementation of the Affordable Care Act, the mandate for preventative

Is Preventive Care the Future of Malaysia’s Healthcare?
Public Policy Is Preventive Care the Future of Malaysia’s Healthcare?

For decades, the success of the Malaysian medical system was measured by the sheer height of its hospital towers and the number of specialized beds available to the public. This long-standing obsession with physical infrastructure has created a paradox where a world-class reactive system struggles

How Is Telemedicine Shaping the European Medical Cannabis Market?
Public Policy How Is Telemedicine Shaping the European Medical Cannabis Market?

The rapid expansion of specialized digital health platforms has fundamentally altered how patients interact with the medical cannabis market across the European continent through the use of integrated technological solutions. Digital prescription platforms and cross-border physician networks now

The Crisis of U.S. Healthcare Reform and Market Failures
Public Policy The Crisis of U.S. Healthcare Reform and Market Failures

The American healthcare infrastructure currently stands at a precarious crossroads where the relentless escalation of delivery costs threatens to destabilize the broader national economy while political attention remains diverted by international volatility. This multi-trillion-dollar industry has

FDA Approves Zongertinib for HER2-Mutant Lung Cancer
Public Policy FDA Approves Zongertinib for HER2-Mutant Lung Cancer

Precision Oncology and the Evolution of Targeted Lung Cancer Therapies The landscape of thoracic oncology has shifted dramatically as pharmaceutical innovation increasingly focuses on the granular genetic drivers that dictate tumor behavior in non-small cell lung cancer. This evolution marks a

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later